BCOP Self-Study
These modules focus on literature published within the last two years. Participants will learn about new developments and cutting-edge findings through case-based discussions that help you apply the information presented.
Self-Study 2025 Release II is now available - it contains 11 ACPE and BCOP CEs total.
Individual Learning Opportunities
Clear filter
-
IndividualLearn more
Self-Study 2026: Bias in Clinical Trial Enrollment: Addressing Disparities in Underserved Populations
On-demand This self-study examines how bias enters clinical trial enrollment through protocol design, site selection, and operational decisions, and reviews practical evidence-informed strategies to address these barriers within U.S.-based oncology research. -
IndividualLearn more
Self-Study 2026: Cancer Cachexia Management (phase 2 in pipeline)
On-demand This module will explore recent updates to guidelines based on emerging literature as well as a review of phase 2 agents in the pipeline. -
IndividualLearn more
Self-Study 2026: Updates on Anti-HER2 Therapies in Non-Small Cell Lung Cancer
On-demand Treatment options for HER2-altered NSCLC may include tyrosine kinase inhibitors (TKIs) and antibody-drug conjugates (ADC). Research is ongoing, with clinical trials exploring new combinations and agents for HER2-altered NSCLC. -
IndividualLearn more
Self-Study 2026: Updates on Treatments for Adult Acute Lymphoblastic Leukemia
On-demand This session will review recent literature describing newly developed regimens and therapeutic agents for the treatment of ALL with a focus on adult B-cell ALL. -
IndividualLearn more
Self-Study 2026: Utilization of Minimal Residual Disease (MRD) in Oncology
On-demand This module will explore the evolution, current relevance, and challenges of MRD testing beyond biomarker-directed therapeutic agents. -
IndividualLearn more
Self-Study 2026: Neuroendocrine Tumors
On-demand This module delves into neuroendocrine tumor classification, while exploring complications such as carcinoid syndrome. -
IndividualLearn more
Self-Study 2026: Cancer Screenings & Genetic Syndromes
On-demand Guideline-directed screening, risk-reduction strategies, and multidisciplinary care, including genetic counseling before and after germline testing, are essential to optimize outcomes and reduce cancer-related morbidity and mortality. -
IndividualLearn more
Self-Study 2025 Release II: Review of CNS Prophylaxis in Hematologic Malignancies
On-demand At the end of this self-study course, you will have the tools to administer preventative CNS-directed therapy that balances efficacy and toxicity with the patient's overall goals of care. -
IndividualLearn more
Self-Study 2025 Release II: Gene Therapy Advances in Hemophilia, Sickle Cell Disease, and Beta-Thalassemia
On-demand In this module, we will explore the different mechanisms of action of available agents and their varied impact on target diseases. Readers will also consider the challenges to incorporating gene therapies into routine care of individuals with hemophilia, sickle cell disease, and beta-thalassemia. -
IndividualLearn more
Self-Study 2025 Release II: The Four Body Problem: Four Drug Regimens in Newly Diagnosed Multiple Myeloma
On-demand This module will review the safety and efficacy of four-drug regimens for the treatment of newly diagnosed multiple myeloma. -
IndividualLearn more
Self-Study 2025 Release II: Updates in the Treatment of Hormone Receptor-Positive (HR+) Metastatic Breast Cancer
On-demand In this module, participants will evaluate the recent data behind imlunestrant, inavolisib, trastuzumab deruxtecan, and datopotamab deruxtecan and explore the clinical situations in which the utilization of these agents would be appropriate. -
IndividualLearn more
Self-Study 2025 Release II: Antibody Drug Conjugates (ADCs) in Solid Tumors
On-demand This module will provide an overview of ADCs structure, including monoclonal antibody, linker, and cytotoxic agent, while also briefly discussing key factors that impact ADC toxicity profiles.